Gene expression changes were determined by Affymetrix microarray analysis in HNSCC cells treated for 4 days with AZD8010, an FGFR-specific TKI [18], gefitinib, an EGFR-specific TKI, or the combination of both TKIs. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.